These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 12052195)

  • 1. Application of ligand SAR, receptor modeling and receptor mutagenesis to the discovery and development of a new class of 5-HT(2A) ligands.
    Westkaemper RB; Glennon RA
    Curr Top Med Chem; 2002 Jun; 2(6):575-98. PubMed ID: 12052195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spiro[9,10-dihydroanthracene]-9,3'-pyrrolidine-a structurally unique tetracyclic 5-HT2A receptor antagonist.
    Peddi S; Roth BL; Glennon RA; Westkaemper RB
    Eur J Pharmacol; 2003 Dec; 482(1-3):335-7. PubMed ID: 14660041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 9-(Aminomethyl)-9,10-dihydroanthracene is a novel and unlikely 5-HT2A receptor antagonist.
    Westkaemper RB; Runyon SP; Bondarev ML; Savage JE; Roth BL; Glennon RA
    Eur J Pharmacol; 1999 Sep; 380(1):R5-7. PubMed ID: 10513561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of chain length and N-alkylation on the selective serotonin receptor ligand 9-(aminomethyl)-9,10-dihydroanthracene.
    Runyon SP; Savage JE; Taroua M; Roth BL; Glennon RA; Westkaemper RB
    Bioorg Med Chem Lett; 2001 Mar; 11(5):655-8. PubMed ID: 11266163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Geometry-affinity relationships of the selective serotonin receptor ligand 9-(aminomethyl)-9,10-dihydroanthracene.
    Runyon SP; Peddi S; Savage JE; Roth BL; Glennon RA; Westkaemper RB
    J Med Chem; 2002 Apr; 45(8):1656-64. PubMed ID: 11931619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential modes of interaction of 9-aminomethyl-9,10-dihydroanthracene (AMDA) derivatives with the 5-HT2A receptor: a ligand structure-affinity relationship, receptor mutagenesis and receptor modeling investigation.
    Runyon SP; Mosier PD; Roth BL; Glennon RA; Westkaemper RB
    J Med Chem; 2008 Nov; 51(21):6808-28. PubMed ID: 18847250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ketanserin and spiperone as templates for novel serotonin 5-HT(2A) antagonists.
    Glennon RA; Metwally K; Dukat M; Ismaiel AM; De los Angeles J; Herndon J; Teitler M; Khorana N
    Curr Top Med Chem; 2002 Jun; 2(6):539-58. PubMed ID: 12052193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring the relationship between binding modes of 9-(aminomethyl)-9,10-dihydroanthracene and cyproheptadine analogues at the 5-HT2A serotonin receptor.
    Westkaemper RB; Runyon SP; Savage JE; Roth BL; Glennon RA
    Bioorg Med Chem Lett; 2001 Feb; 11(4):563-6. PubMed ID: 11229772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-HT(4) receptor antagonists: structure-affinity relationships and ligand-receptor interactions.
    López-Rodriguez ML; Benhamú B; Morcillo MJ; Murcia M; Viso A; Campillo M; Pardob L
    Curr Top Med Chem; 2002 Jun; 2(6):625-41. PubMed ID: 12052197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 9-Aminomethyl-9,10-dihydroanthracene (AMDA) analogs as structural probes for steric tolerance in 5-HT2A and H1 receptor binding sites.
    Shah JR; Mosier PD; Peddi S; Roth BL; Westkaemper RB
    Bioorg Med Chem Lett; 2010 Feb; 20(3):935-8. PubMed ID: 20045641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, structure-affinity relationships, and modeling of AMDA analogs at 5-HT2A and H1 receptors: structural factors contributing to selectivity.
    Shah JR; Mosier PD; Roth BL; Kellogg GE; Westkaemper RB
    Bioorg Med Chem; 2009 Sep; 17(18):6496-504. PubMed ID: 19700330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New serotonin 5-HT(2A), 5-HT(2B), and 5-HT(2C) receptor antagonists: synthesis, pharmacology, 3D-QSAR, and molecular modeling of (aminoalkyl)benzo and heterocycloalkanones.
    Brea J; Rodrigo J; Carrieri A; Sanz F; Cadavid MI; Enguix MJ; Villazón M; Mengod G; Caro Y; Masaguer CF; Raviña E; Centeno NB; Carotti A; Loza MI
    J Med Chem; 2002 Jan; 45(1):54-71. PubMed ID: 11754579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pyrrolo[1,3]benzothiazepine-based serotonin and dopamine receptor antagonists. Molecular modeling, further structure-activity relationship studies, and identification of novel atypical antipsychotic agents.
    Campiani G; Butini S; Fattorusso C; Catalanotti B; Gemma S; Nacci V; Morelli E; Cagnotto A; Mereghetti I; Mennini T; Carli M; Minetti P; Di Cesare MA; Mastroianni D; Scafetta N; Galletti B; Stasi MA; Castorina M; Pacifici L; Vertechy M; Di Serio S; Ghirardi O; Tinti O; Carminati P
    J Med Chem; 2004 Jan; 47(1):143-57. PubMed ID: 14695828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of the binding sites and selectivity of sarpogrelate, a novel 5-HT2 antagonist, to human 5-HT2A, 5-HT2B and 5-HT2C receptor subtypes by molecular modeling.
    Rashid M; Manivet P; Nishio H; Pratuangdejkul J; Rajab M; Ishiguro M; Launay JM; Nagatomo T
    Life Sci; 2003 May; 73(2):193-207. PubMed ID: 12738034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1-[2-methoxy-5-(3-phenylpropyl)]-2-aminopropane unexpectedly shows 5-HT(2A) serotonin receptor affinity and antagonist character.
    Rangisetty JB; Dukat M; Dowd CS; Herrick-Davis K; DuPre A; Gadepalli S; Teitler M; Kelley CR; Sharif NA; Glennon RA
    J Med Chem; 2001 Sep; 44(20):3283-91. PubMed ID: 11563927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and structure-activity relationships of a new model of arylpiperazines. Study of the 5-HT(1a)/alpha(1)-adrenergic receptor affinity by classical hansch analysis, artificial neural networks, and computational simulation of ligand recognition.
    López-Rodríguez ML; Morcillo MJ; Fernández E; Rosado ML; Pardo L; Schaper K
    J Med Chem; 2001 Jan; 44(2):198-207. PubMed ID: 11170629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and pharmacological evaluation of 1-[(1,2-diphenyl-1H-4-imidazolyl)methyl]-4-phenylpiperazines with clozapine-like mixed activities at dopamine D(2), serotonin, and GABA(A) receptors.
    Asproni B; Pau A; Bitti M; Melosu M; Cerri R; Dazzi L; Seu E; Maciocco E; Sanna E; Busonero F; Talani G; Pusceddu L; Altomare C; Trapani G; Biggio G
    J Med Chem; 2002 Oct; 45(21):4655-68. PubMed ID: 12361392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2,5-Disubstituted pyridines: the discovery of a novel series of 5-HT2A ligands.
    Wilson KJ; van Niel MB; Cooper L; Bloomfield D; O'Connor D; Fish LR; MacLeod AM
    Bioorg Med Chem Lett; 2007 May; 17(9):2643-8. PubMed ID: 17314044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 7-Arylpiperazinylalkyl and 7-tetrahydroisoquinolinylalkyl derivatives of 8-alkoxy-purine-2,6-dione and some of their purine-2,6,8-trione analogs as 5-HT(1A), 5-HT(2A), and 5-HT(7) serotonin receptor ligands.
    Chłoń-Rzepa G; Zmudzki P; Zajdel P; Bojarski AJ; Duszyńska B; Nikiforuk A; Tatarczyńska E; Pawłowski M
    Bioorg Med Chem; 2007 Aug; 15(15):5239-50. PubMed ID: 17517514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1-[4-(3-Phenylalkyl)phenyl]-2-aminopropanes as 5-HT(2A) partial agonists.
    Dowd CS; Herrick-Davis K; Egan C; DuPre A; Smith C; Teitler M; Glennon RA
    J Med Chem; 2000 Aug; 43(16):3074-84. PubMed ID: 10956215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.